Showing results (221-230 of 969) with videos related to
Sort By:
Pageof 97
American Journal of Hematology|August 5, 2021
Development of TP53 mutations over the course of therapy for acute myeloid leukemiaYasmin Alwash, Joseph D Khoury, Mehrnoosh Tashakori, et al.Cancer|October 15, 2016
Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agentsElias Jabbour, Stefan Faderl, Koji Sasaki, et al.Leukemia Research|April 19, 2025
Safety and efficacy of the combination of azacitidine with venetoclax after hypomethylating agent failure in higher-risk myelodysplastic syndromeJulie S Braish, Guillermo Montalban-Bravo, Farhad Ravandi, et al.Leukemia & Lymphoma|July 7, 2017
The emerging role of immune checkpoint based approaches in AML and MDSPrajwal Boddu, Hagop Kantarjian, Guillermo Garcia-Manero, et al.Future Oncology (London, England)|September 28, 2019
Quizartinib in the treatment of FLT3-internal-tandem duplication-positive acute myeloid leukemiaShilpa Paul, Adam J DiPippo, Farhad Ravandi, et al.Future Oncology (London, England)|August 2, 2013
Elacytarabine (CP-4055) in the treatment of acute myeloid leukemiaCourtney D DiNardo, Susan O'Brien, Varsha V Gandhi, et al.Seminars in Hematology|November 20, 2013
Targeted therapies in hematology and their impact on patient care: chronic and acute myeloid leukemiaElias Jabbour, Jorge Cortes, Farhad Ravandi, et al.Expert Opinion on Investigational Drugs|April 23, 2014
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Michael Andreeff, et al.Cancer|June 19, 2012
Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008Yiming Chen, Hagop Kantarjian, Haijun Wang, et al.Current Treatment Options in Oncology|January 25, 2019
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaIman Abou Dalle, Elias Jabbour, Nicholas J Short, et al.Pageof 97